Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 256 AL 270

Role of Natural Plant Products Against Alzheimer's Disease

Varshney H, Siddique YH.

CNS Neurol Disord Drug Targets. 2021;20(10):904-941. doi: 10.2174/1871527320666210420135437.

Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data

Gallini A, Jegou D, Lapeyre-Mestre M, Couret A, Bourrel R, Ousset PJ, Fabre D, Andrieu S, Gardette V.

Curr Alzheimer Res. 2021;18(2):142-156. doi: 10.2174/1567205018666210416094639.

Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review

Fernandes LCB, Costa IM, Freire MAM, Lima FOV, Neta FI, de Souza Lucena EE, Alves RD, Cavalcanti JRLP, Pinheiro FI, de Azevedo EP, Freitas CIA, Guzen FP.

Curr Neuropharmacol. 2021;19(10):1738-1759. doi: 10.2174/1570159X19666210421091734.

Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M(1) receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study

Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Doll RJ, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.

Alzheimers Res Ther. 2021 Apr 21;13(1):87. doi: 10.1186/s13195-021-00816-5.

Multisite transcranial direct current stimulation associated with cognitive training in episodic memory and executive functions in individuals with Alzheimer's disease: a case report

Marchi LZ, Ferreira RGD, de Lima GNS, da Silva JAS, da Cruz DMC, Fernandez-Calvo B, Andrade SMMDS.

J Med Case Rep. 2021 Apr 22;15(1):185. doi: 10.1186/s13256-021-02800-x.

How understudied populations have contributed to our understanding of Alzheimer's disease genetics

Dehghani N, Bras J, Guerreiro R.

Brain. 2021 May 7;144(4):1067-1081. doi: 10.1093/brain/awab028.

A current view on Tau protein phosphorylation in Alzheimer's disease

Wegmann S, Biernat J, Mandelkow E.

Curr Opin Neurobiol. 2021 Aug;69:131-138. doi: 10.1016/j.conb.2021.03.003. Epub 2021 Apr 21.

Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes

Radbakhsh S, Barreto GE, Bland AR, Sahebkar A.

Biofactors. 2021 Jul;47(4):570-586. doi: 10.1002/biof.1735. Epub 2021 Apr 24.

A patent review of glutaminyl cyclase inhibitors (2004-present)

Coimbra JRM, Salvador JAR.

Expert Opin Ther Pat. 2021 Sep;31(9):809-836. doi: 10.1080/13543776.2021.1917549. Epub 2021 Jul 5.

The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease

Nerg O, Junkkari A, Hallikainen I, Rauramaa T, Luikku A, Hiltunen M, Jääskeläinen JE, Leinonen V, Hänninen T, Koivisto A.

J Alzheimers Dis. 2021;81(3):1117-1130. doi: 10.3233/JAD-201363.

Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease

Terada T, Therriault J, Kang MSP, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Matsudaira T, Bunai T, Obi T, Tsukada H, Ouchi Y, Rosa-Neto P.

Mol Neurodegener. 2021 Apr 26;16(1):28. doi: 10.1186/s13024-021-00448-1.

Sex-specific DNA methylation differences in Alzheimer's disease pathology

Zhang L, Young JI, Gomez L, Silva TC, Schmidt MA, Cai J, Chen X, Martin ER, Wang L.

Acta Neuropathol Commun. 2021 Apr 26;9(1):77. doi: 10.1186/s40478-021-01177-8.

Classification of patients with Alzheimer's disease using the arterial pulse spectrum and a multilayer-perceptron analysis

Lin SK, Hsiu H, Chen HS, Yang CJ.

Sci Rep. 2021 Apr 26;11(1):8882. doi: 10.1038/s41598-021-87903-7.

Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies

Hosseini L, Mahmoudi J, Pashazadeh F, Salehi-Pourmehr H, Sadigh-Eteghad S.

J Mol Neurosci. 2021 Jul;71(7):1425-1435. doi: 10.1007/s12031-021-01842-6. Epub 2021 Apr 28.

Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease

Srivastava S, Rajopadhye R, Dey M, Singh RK.

Expert Opin Ther Targets. 2021 Apr;25(4):243-247. doi: 10.1080/14728222.2021.1924151. Epub 2021 May 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias